Format

Send to

Choose Destination
Endocr Relat Cancer. 2014 Oct;21(5):R409-29. doi: 10.1530/ERC-14-0208. Epub 2014 Jul 25.

Interplay between steroid signalling and microRNAs: implications for hormone-dependent cancers.

Author information

1
Department of Surgery and CancerImperial College London, Imperial Centre for Translational and Experimental Medicine, Du Cane Road, London W12 0NN, UKCardiff University School of MedicineCardiff University Peking University Cancer Institute, Cardiff CF14 4XN, UK.
2
Department of Surgery and CancerImperial College London, Imperial Centre for Translational and Experimental Medicine, Du Cane Road, London W12 0NN, UKCardiff University School of MedicineCardiff University Peking University Cancer Institute, Cardiff CF14 4XN, UK Department of Surgery and CancerImperial College London, Imperial Centre for Translational and Experimental Medicine, Du Cane Road, London W12 0NN, UKCardiff University School of MedicineCardiff University Peking University Cancer Institute, Cardiff CF14 4XN, UK.
3
Department of Surgery and CancerImperial College London, Imperial Centre for Translational and Experimental Medicine, Du Cane Road, London W12 0NN, UKCardiff University School of MedicineCardiff University Peking University Cancer Institute, Cardiff CF14 4XN, UK Charlotte.bevan@imperial.ac.uk.

Abstract

Hormones are key drivers of cancer development. To date, interest has largely been focussed on the classical model of hormonal gene regulation, but there is increasing evidence for a role of hormone signalling pathways in post-translational regulation of gene expression. In particular, a complex and dynamic network of bi-directional interactions with microRNAs (miRs) at all stages of biogenesis and during target gene repression is emerging. miRs, which act mainly by negatively regulating gene expression through association with 3'-UTRs of mRNA species, are increasingly understood to be important in development, normal physiology and pathogenesis. Given recent demonstrations of altered miR profiles in a diverse range of cancers, their ability to function as oncogenes or tumour suppressors, and hormonal regulation of miRs, understanding mechanisms by which miRs are generated and regulated is vitally important. miRs are transcribed by RNA polymerase II and then processed in the nucleus by the Drosha-containing Microprocessor complex and in the cytoplasm by Dicer, before mature miRs are incorporated into the RNA-induced silencing complex. It is increasingly evident that multiple cellular signalling pathways converge upon the miR biogenesis cascade, adding further layers of regulatory complexity to modulate miR maturation. This review summarises recent advances in identification of novel components and regulators of the Microprocessor and Dicer complexes, with particular emphasis on the role of hormone signalling pathways in regulating their activity. Understanding hormone regulation of miR production and how this is perturbed in cancer are critical for the development of miR-based therapeutics and biomarkers.

KEYWORDS:

Dicer; Drosha; androgen; breast; estrogen; microRNA; microprocessor; prostate

PMID:
25062737
DOI:
10.1530/ERC-14-0208
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Sheridan PubFactory Icon for Spiral, Imperial College Digital Repository
Loading ...
Support Center